Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| SAB Biotherapeutics, Inc. | 2,198,457 | reported | 29 Sept 2025 | tx 16+7,011,238−78,207 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 Sept 2025 | EXERCISE | SAB Biotherapeutics, Inc. | 1,740,000 | 1.75 USD | |
| 29 Sept 2025 | EXERCISE | SAB Biotherapeutics, Inc. | 17,400 | — | deriv |
| 22 Jul 2025 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 114,250 | — | deriv |
| 22 Jul 2025 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 228,500 | — | deriv |
| 22 Jul 2025 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 228,500 | — | deriv |
| 24 Nov 2023 | EXERCISE | SAB Biotherapeutics, Inc. | 4,584,571 | — | |
| 24 Nov 2023 | EXERCISE | SAB Biotherapeutics, Inc. | 28,380 | 1000.00 USD | deriv |
| 24 Nov 2023 | EXERCISE | SAB Biotherapeutics, Inc. | 31,269 | 1000.00 USD | deriv |
| 13 Nov 2023 | EXERCISE | SAB Biotherapeutics, Inc. | 13,269 | — | deriv |
| 10 Nov 2023 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 22,115 | — | deriv |
| 10 Nov 2023 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 8,846 | — | deriv |
| 13 Nov 2023 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 13,269 | 1000.00 USD | deriv |
| 10 Nov 2023 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 13,269 | — | deriv |
| 23 Oct 2023 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 16,269 | 1000.00 USD | deriv |
| 23 Oct 2023 | EXERCISE | SAB Biotherapeutics, Inc. | 16,269 | — | deriv |